By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verastem, Inc. 

215 First Street
Suite 440
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-858-0338 Fax: n/a


Company News
Verastem (VSTM) Stops Study of Experimental Cancer Therapy; Stock Plunges 9/28/2015 7:12:56 AM
Verastem (VSTM) Announces New Research Published In The Journal Cell That Highlights The Potential Of FAK Inhibition To Enhance The Efficacy Of Anti-Tumor Immunotherapy 9/25/2015 10:23:01 AM
Verastem (VSTM) To Present Preclinical Data At ESMO/ECCO 2015 9/17/2015 1:26:37 PM
Verastem (VSTM) To Present At Rodman & Renshaw 17th Annual Global Investment Conference 9/4/2015 7:34:18 AM
Verastem (VSTM) Issues Statement Regarding WCLC Presentations 8/27/2015 8:46:59 AM
In Response to Twitter Rumors and Phase II Data, Verastem (VSTM) Stock Plunges 8/27/2015 6:00:03 AM
Verastem, Inc. (VSTM) To Present Data At The 16th World Conference On Lung Cancer 8/26/2015 11:05:02 AM
Verastem, Inc. (VSTM) Reports Second Quarter 2015 Financial And Corporate Results 8/10/2015 10:01:55 AM
Verastem, Inc. (VSTM) To Present At Cantor Fitzgerald’s Inaugural Health Care Conference 7/2/2015 11:23:00 AM
Verastem, Inc. (VSTM) To Present At 2015 JMP Securities Life Sciences Conference 6/17/2015 10:23:04 AM